NewGenIvf Group Limited (NIVF)
NASDAQ: NIVF · Real-Time Price · USD
0.333
-0.008 (-2.46%)
At close: Dec 20, 2024, 4:00 PM
0.318
-0.015 (-4.53%)
After-hours: Dec 20, 2024, 7:59 PM EST

NewGenIvf Group Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21
Revenue
5.685.145.944.12
Revenue Growth (YoY)
-4.46%-13.59%44.34%-
Cost of Revenue
4.193.454.413.09
Gross Profit
1.481.681.541.02
Selling, General & Admin
1.321.641.140.83
Operating Expenses
1.321.641.140.83
Operating Income
0.160.040.40.2
Interest Expense
-0.38-0.05-0.08-0.09
Interest & Investment Income
0000
Other Non Operating Income (Expenses)
0.10.110.020.05
Pretax Income
-0.120.110.340.16
Income Tax Expense
-0.08-0.210.29
Earnings From Continuing Operations
-0.040.110.14-0.14
Minority Interest in Earnings
-0.040.020.320.14
Net Income
-0.080.130.46-0
Net Income to Common
-0.080.130.46-0
Net Income Growth
--71.61%--
Shares Outstanding (Basic)
8111
Shares Outstanding (Diluted)
8111
Shares Change (YoY)
1250.13%6.81%2.84%-
EPS (Basic)
-0.010.210.80-0.00
EPS (Diluted)
-0.010.210.80-0.00
EPS Growth
--73.42%--
Free Cash Flow
-2.89-1.841.621.42
Free Cash Flow Per Share
-0.37-2.982.812.53
Gross Margin
26.14%32.74%25.87%24.88%
Operating Margin
2.84%0.82%6.71%4.83%
Profit Margin
-1.42%2.53%7.72%-0.01%
Free Cash Flow Margin
-50.93%-35.75%27.19%34.39%
EBITDA
0.210.070.50.37
EBITDA Margin
3.63%1.43%8.40%8.87%
D&A For EBITDA
0.040.030.10.17
EBIT
0.160.040.40.2
EBIT Margin
2.84%0.82%6.71%4.83%
Effective Tax Rate
--60.51%188.70%
Source: S&P Capital IQ. Standard template. Financial Sources.